
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Lactate modulates CD4+ T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis
Giuseppina Comito, Anthony Iscaro, Marina Bacci, et al.
Oncogene (2019) Vol. 38, Iss. 19, pp. 3681-3695
Closed Access | Times Cited: 179
Giuseppina Comito, Anthony Iscaro, Marina Bacci, et al.
Oncogene (2019) Vol. 38, Iss. 19, pp. 3681-3695
Closed Access | Times Cited: 179
Showing 1-25 of 179 citing articles:
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
Xiaoqi Mao, Jin Xu, Wei Wang, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 1426
Xiaoqi Mao, Jin Xu, Wei Wang, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 1426
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
Tongyan Liu, Chencheng Han, Siwei Wang, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 709
Tongyan Liu, Chencheng Han, Siwei Wang, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 709
The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment
Lea Monteran, Neta Erez
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 556
Lea Monteran, Neta Erez
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 556
Lactate in the tumour microenvironment: From immune modulation to therapy
Zi-Hao Wang, Wenbei Peng, Pei Zhang, et al.
EBioMedicine (2021) Vol. 73, pp. 103627-103627
Open Access | Times Cited: 276
Zi-Hao Wang, Wenbei Peng, Pei Zhang, et al.
EBioMedicine (2021) Vol. 73, pp. 103627-103627
Open Access | Times Cited: 276
Hypoxia, Metabolic Reprogramming, and Drug Resistance in Liver Cancer
Macus Hao‐Ran Bao, Carmen Chak‐Lui Wong
Cells (2021) Vol. 10, Iss. 7, pp. 1715-1715
Open Access | Times Cited: 230
Macus Hao‐Ran Bao, Carmen Chak‐Lui Wong
Cells (2021) Vol. 10, Iss. 7, pp. 1715-1715
Open Access | Times Cited: 230
Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies
Shohei Koyama, Hiroyoshi Nishikawa
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 7, pp. e002591-e002591
Open Access | Times Cited: 219
Shohei Koyama, Hiroyoshi Nishikawa
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 7, pp. e002591-e002591
Open Access | Times Cited: 219
Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies
Rana Mhaidly, Fatima Mechta‐Grigoriou
Seminars in Immunology (2020) Vol. 48, pp. 101417-101417
Open Access | Times Cited: 205
Rana Mhaidly, Fatima Mechta‐Grigoriou
Seminars in Immunology (2020) Vol. 48, pp. 101417-101417
Open Access | Times Cited: 205
Role of cancer‐associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer
Rana Mhaidly, Fatima Mechta‐Grigoriou
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 259-272
Open Access | Times Cited: 163
Rana Mhaidly, Fatima Mechta‐Grigoriou
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 259-272
Open Access | Times Cited: 163
Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression
Lihua Chen, Lixiang Huang, Yu Gu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11943-11943
Open Access | Times Cited: 163
Lihua Chen, Lixiang Huang, Yu Gu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11943-11943
Open Access | Times Cited: 163
Crosstalk between glucose metabolism, lactate production and immune response modulation
Lei Ye, Yi Jiang, Mingming Zhang
Cytokine & Growth Factor Reviews (2022) Vol. 68, pp. 81-92
Closed Access | Times Cited: 147
Lei Ye, Yi Jiang, Mingming Zhang
Cytokine & Growth Factor Reviews (2022) Vol. 68, pp. 81-92
Closed Access | Times Cited: 147
Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures
Bing Feng, Jian Wu, Bo Shen, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 113
Bing Feng, Jian Wu, Bo Shen, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 113
Lactate Rewires Lipid Metabolism and Sustains a Metabolic–Epigenetic Axis in Prostate Cancer
Luigi Ippolito, Giuseppina Comito, Matteo Parri, et al.
Cancer Research (2022) Vol. 82, Iss. 7, pp. 1267-1282
Open Access | Times Cited: 104
Luigi Ippolito, Giuseppina Comito, Matteo Parri, et al.
Cancer Research (2022) Vol. 82, Iss. 7, pp. 1267-1282
Open Access | Times Cited: 104
Metabolic reprogramming in cholangiocarcinoma
Chiara Raggi, Maria Letizia Taddei, Colin Rae, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 3, pp. 849-864
Open Access | Times Cited: 99
Chiara Raggi, Maria Letizia Taddei, Colin Rae, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 3, pp. 849-864
Open Access | Times Cited: 99
The Warburg effect: a score for many instruments in the concert of cancer and cancer niche cells
Martyna Jaworska, Julia Szczudło, Adrian Pietrzyk, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 4, pp. 876-890
Open Access | Times Cited: 60
Martyna Jaworska, Julia Szczudło, Adrian Pietrzyk, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 4, pp. 876-890
Open Access | Times Cited: 60
CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy?
Chunxue Zhang, Yuxiang Fei, Hui Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 58
Chunxue Zhang, Yuxiang Fei, Hui Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 58
Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer
Moumita Kundu, Ramesh Butti, Venketesh K. Panda, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 48
Moumita Kundu, Ramesh Butti, Venketesh K. Panda, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 48
How protons pave the way to aggressive cancers
Pawel Swietach, Ebbe Boedtkjer, Stine F. Pedersen
Nature reviews. Cancer (2023) Vol. 23, Iss. 12, pp. 825-841
Closed Access | Times Cited: 43
Pawel Swietach, Ebbe Boedtkjer, Stine F. Pedersen
Nature reviews. Cancer (2023) Vol. 23, Iss. 12, pp. 825-841
Closed Access | Times Cited: 43
Histone lactylation: from tumor lactate metabolism to epigenetic regulation
Xiaoning Yu, Jing Yang, Jin Xu, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 5, pp. 1833-1854
Open Access | Times Cited: 28
Xiaoning Yu, Jing Yang, Jin Xu, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 5, pp. 1833-1854
Open Access | Times Cited: 28
Lactate and lactylation: Behind the development of tumors
Enci Dai, Wei Wang, Yingying Li, et al.
Cancer Letters (2024) Vol. 591, pp. 216896-216896
Closed Access | Times Cited: 28
Enci Dai, Wei Wang, Yingying Li, et al.
Cancer Letters (2024) Vol. 591, pp. 216896-216896
Closed Access | Times Cited: 28
Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours
Kamilla J. A. Bigos, Conrado Guerrero Quiles, Sapna Lunj, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 27
Kamilla J. A. Bigos, Conrado Guerrero Quiles, Sapna Lunj, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 27
Beyond the Barrier: Unraveling the Mechanisms of Immunotherapy Resistance
Hannah N. Bell, Weiping Zou
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 521-550
Closed Access | Times Cited: 25
Hannah N. Bell, Weiping Zou
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 521-550
Closed Access | Times Cited: 25
Fibroblasts Fuel Immune Escape in the Tumor Microenvironment
Emiel A. De Jaeghere, Hannelore Denys, Olivier De Wever
Trends in cancer (2019) Vol. 5, Iss. 11, pp. 704-723
Closed Access | Times Cited: 134
Emiel A. De Jaeghere, Hannelore Denys, Olivier De Wever
Trends in cancer (2019) Vol. 5, Iss. 11, pp. 704-723
Closed Access | Times Cited: 134
The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment
Conall Hayes, Claire L. Donohoe, Maria Davern, et al.
Cancer Letters (2020) Vol. 500, pp. 75-86
Open Access | Times Cited: 127
Conall Hayes, Claire L. Donohoe, Maria Davern, et al.
Cancer Letters (2020) Vol. 500, pp. 75-86
Open Access | Times Cited: 127
Cancer-Associated Fibroblasts: Understanding Their Heterogeneity
Kévin Louault, Rongrong Li, Yves A. DeClerck
Cancers (2020) Vol. 12, Iss. 11, pp. 3108-3108
Open Access | Times Cited: 115
Kévin Louault, Rongrong Li, Yves A. DeClerck
Cancers (2020) Vol. 12, Iss. 11, pp. 3108-3108
Open Access | Times Cited: 115
The immunological Warburg effect: Can a metabolic‐tumor‐stroma score (MeTS) guide cancer immunotherapy?
Peter J. Siska, Katrin Singer, Katja Evert, et al.
Immunological Reviews (2020) Vol. 295, Iss. 1, pp. 187-202
Open Access | Times Cited: 97
Peter J. Siska, Katrin Singer, Katja Evert, et al.
Immunological Reviews (2020) Vol. 295, Iss. 1, pp. 187-202
Open Access | Times Cited: 97